Related Experiment Video

Updated: Aug 18, 2026

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa
13:40

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa

Published on: February 17, 2014

Puromycin-resistant biosynthesis of a specific outer-membrane lipoprotein of Escherichia coli

S Halegoua, A Hirashima, M Inouye

    Journal of Bacteriology
    |April 1, 1976
    PubMed

    Insights

    Puromycin resistance in Escherichia coli lipoprotein biosynthesis was investigated. The lipoprotein machinery showed intrinsic resistance to puromycin, even when cell structures were disrupted.

    Area of Science:

    • Microbiology
    • Molecular Biology
    • Biochemistry

    Background:

    • Escherichia coli outer-membrane lipoproteins are essential for bacterial cell structure and function.
    • Puromycin is an antibiotic that inhibits protein synthesis by interfering with ribosome function.

    Purpose of the Study:

    • To investigate the reported puromycin resistance of in vivo lipoprotein biosynthesis in Escherichia coli.
    • To determine if this resistance is an intrinsic property of the lipoprotein biosynthetic machinery.

    Main Methods:

    • Investigated puromycin resistance in intact Escherichia coli cells.
    • Disrupted cell structures using ethylenediaminetetraacetate (EDTA) and toluene to increase puromycin accessibility.
    • Utilized an in vitro protein biosynthesis system with polyribosomes.

    Main Results:

    • Overall protein synthesis sensitivity to puromycin increased approximately 10-fold with cell disruption.
    • Lipoprotein biosynthesis consistently remained more resistant to puromycin than other protein syntheses across all tested systems.
    • Determined 50% inhibition concentrations for puromycin in intact cells, EDTA-treated, toluene-treated, and polyribosome systems.

    Conclusions:

    • The puromycin resistance of Escherichia coli lipoprotein biosynthesis is likely due to an intrinsic characteristic of its specific biosynthetic machinery.
    • This intrinsic resistance mechanism warrants further investigation to understand its molecular basis.

    More Related Videos

    Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification10:21

    Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification

    Published on: November 16, 2016

    Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing08:19

    Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

    Published on: July 7, 2020

    Related Concept Videos

    Stringent Response in E. coli01:23

    Stringent Response in E. coli

    Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
    Development of Antibiotic Resistance01:30

    Development of Antibiotic Resistance

    Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Inhibitors of Gram-positive Cell Wall Synthesis01:23

    Inhibitors of Gram-positive Cell Wall Synthesis

    Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...